(Q44384641)

2 December 2017

Results of two clinical trials on the safety and efficacy of pravastatin 80 and 160 mg per day. (English)

1 reference

2 December 2017

Robert S Rosenson

1

1 reference

PubMed ID

12667578

2 December 2017

Harold E Bays

series ordinal

2

1 reference

PubMed ID

12667578

2 December 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

American Journal of Cardiology

2 December 2017

1 reference

2 December 2017

91

1 reference

2 December 2017

7

1 reference

2 December 2017

878-881

1 reference

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900026-2

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900026-2

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900026-2

Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900026-2

Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900026-2

Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900026-2

Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900026-2

10.1016/S0002-9149(03)00026-2

7 January 2021

Identifiers

DOI

1 reference

2 December 2017

1 reference

PubMed ID

12667578